Press release
Gene Delivery Technologies Market Demonstrates Long-Term Growth Potential At 14.5% CAGR
Gene Delivery Technologies Market
Projected Market Growth and Size for Gene Delivery Technologies
The gene delivery technologies market is anticipated to escalate rapidly, reaching a valuation of $8.46 billion by 2030. This surge corresponds to a robust compound annual growth rate (CAGR) of 14.5%. The expansion during the forecast period is fueled by the broadening gene therapy pipelines, continuous innovation in delivery vectors, increasing demand for safer methods of gene transfer, growth in applications of cell therapy, and heightened clinical trial activities. Key trends shaping this market include the amplified use of both viral and non-viral delivery systems, broader adoption in gene and cell therapy treatments, advances in lipid nanoparticle technologies, a stronger focus on targeted gene delivery strategies, and improvements in physical gene transfer techniques.
The gene delivery technologies market size has grown rapidly in recent years. It will grow from $4.29 billion in 2025 to $4.92 billion in 2026 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to growth in gene therapy research, development of viral vectors, academic research funding, use of electroporation techniques, vaccine development programs.
Download a free sample of the gene delivery technologies market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10706&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Leading Industry Players in the Gene Delivery Technologies Market
A number of influential companies are driving the gene delivery technologies market forward. Notable players include Thermo Fisher Scientific Inc., QIAGEN NV, Horizon Discovery Group Co., OriGene Technologies Inc., Oxford Biomedica Solutions LLC, SignaGen Laboratories LLC, Vectalys SAS, Takara Bio Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, Promega Corporation, Catalent Inc., Pfizer Inc., Becton dic*kinson and Company, Novartis AG, Intellia Therapeutics Inc., Editas Medicine Inc., CRISPR Therapeutics AG, Spark Therapeutics Inc., Bluebird Bio Inc., Sarepta Therapeutics Inc., Beam Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Translate Bio Inc., CureVac N.V., and Lonza Group AG.
Strategic Acquisition Boosting Gene Therapy Capabilities
In January 2024, Japan-based pharmaceutical firm Kyowa Kirin Co. Ltd. finalized the acquisition of UK-based Orchard Therapeutics plc, a biopharmaceutical company specializing in gene therapies. Although the financial details were not disclosed, this move aims to strengthen Kyowa Kirin's gene therapy portfolio by leveraging Orchard Therapeutics' expertise in hematopoietic stem cell (HSC) gene therapies. The acquisition is expected to expand patient access to transformative treatments targeting rare genetic diseases.
View the full gene delivery technologies market report:
https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Emerging Innovations and Future Trends in Gene Delivery Technologies
Industry leaders are focusing on cutting-edge product development to maintain a competitive advantage. One example is Agilent Technologies' launch of the ProteoAnalyzer system in July 2024. This advanced automated platform uses parallel capillary electrophoresis (CE) technology for rapid and high-resolution protein analysis with minimal sample requirements. Targeted at researchers dealing with complex protein mixtures in pharmaceuticals, biopharma, and bioengineered food ingredients, the ProteoAnalyzer facilitates faster translational research and therapeutic protein development by offering detailed examination capabilities.
Comprehensive Market Segmentation for Gene Delivery Technologies
The gene delivery technologies market is divided into various segments to reflect its broad scope:
1) By Mode of Delivery: Biological, Chemical, Physical
2) By Method of Application: Ex Vivo, In Vivo, In Vitro
3) By Application Area: Gene Therapy, Cell Therapy, Vaccines, Research
Further detailed subcategories include:
- Biological: Viral Vectors, Bacterial Vectors, Lipid Nanoparticles
- Chemical: Cationic Lipids, Polymers, Chemical Transfection Agents
- Physical: Electroporation, Microinjection, Gene Gun, Sonoporation
These classifications help provide a clear understanding of the diverse techniques and uses within the gene delivery technologies market, highlighting its complexity and potential for innovation.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene Delivery Technologies Market Demonstrates Long-Term Growth Potential At 14.5% CAGR here
News-ID: 4607472 • Views: …
More Releases from The Business Research Company
Micropropagation Market Report 2026 Market Outlook Supported By A Forecast 9% CA …
The micropropagation market is gaining significant attention as a vital method for plant multiplication and cultivation. With the growing demand for sustainable agriculture and technological advances, this sector is on track for substantial growth. Let's explore the market size, emerging players, key trends, and segmentation that define the micropropagation industry today.
Projected Growth and Market Size of the Micropropagation Market
The micropropagation market is set to experience robust expansion over…
Microbiology And Bacterial Culture Media Market Insights Highlight Segment Expan …
The microbiology and bacterial culture media market is poised for significant expansion as it continues to play a vital role in healthcare, research, and industrial sectors. With evolving technologies and increasing demand for efficient microbial testing, this market is set to witness substantial growth and innovation by 2030.
Projected Growth and Market Size in the Microbiology and Bacterial Culture Media Market
Forecasts indicate that the microbiology and bacterial culture media…
Microbial Identification Market Report Evaluates Growth Drivers, Challenges And …
The microbial identification market is set to experience substantial expansion over the coming years, driven by cutting-edge technological advancements and increasing demand across various industries. With the integration of innovative tools and methodologies, this sector is poised to reach impressive milestones by 2030. Let's explore the market's size, key players, emerging trends, and segmentation to gain a clearer understanding of its future prospects.
Market Size and Growth Expectations in the Microbial…
Micro Computed Tomography Market Report Provides Insights Into Market Evolution …
The micro computed tomography market is on track for substantial expansion in the coming years, driven by technological advancements and a broadening range of applications. As industries and research fields increasingly embrace this imaging technology, the market is poised for significant growth and innovation through 2030.
Expected Market Size and Growth Trajectory of the Micro Computed Tomography Market
The micro computed tomography market is projected to reach a value of…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
